Alessandra Pavesio's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 61,476 Class A Common Stock done . Disclosure was reported to the exchange on April 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 61,476 | 181,306 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 61,476 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & Chief Science Officer | Sale of securities on an exchange or to another person at price $ 11.17 per share. | 01 Apr 2022 | 32,997 | 148,309 (0%) | 0% | 11.2 | 368,425 | Class A Common Stock |
| Bioventus Inc (Class A) | Alessandra Pavesio | Fmr. SVP & Chief Science Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 96,133 | 96,133 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc (Class A) | Alessandra Pavesio | Fmr. SVP & Chief Science Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 35,545 | 35,545 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & Chief Science Officer | Sale of securities on an exchange or to another person at price $ 11.99 per share. | 14 Feb 2022 | 433 | 119,830 (0%) | 0% | 12.0 | 5,192 | Class A Common Stock |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 1,470 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 1,470 | 120,263 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & CHIEF SCIENCE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 191,708 | 192,708 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & CHIEF SCIENCE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 191,708 | 0 | - | - | Phantom Profit Units | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & CHIEF SCIENCE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.88 per share. | 10 Feb 2022 | 73,915 | 118,793 (0%) | 0% | 12.9 | 952,025 | Class A Common Stock |